My bookmarksSign up free

Commission Implementing Regulation (EU) 2024/1282 of 7 May 2024 amending Implementing Regulation (EU) 2021/128 setting the net balance available for EAGF expenditure

Commission Implementing Regulation (EU) 2024/1282 of 7 May 2024 amending Implementing Regulation (EU) 2021/128 setting the net balance available for EAGF expenditure

Implementing Regulation (EU) 2024/1282 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) 2021/128 is replaced by the text in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the seventh day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX ‘ANNEX Net balance available for EAGF expenditure (EUR million) Budget year Amounts made available to EAFRD Amounts transferred from EAFRD Change following the MFF mid-term revision as set out in Regulation (EU, Euratom) 2024/765 Net balance available for EAGF expenditure Article 14(1) of Regulation (EU) No 1307/2013 Article 7(2) of Regulation (EU) No 1307/2013 Article 14(2) of Regulation (EU) No 1307/2013 2021 1 099,539 58,165 600,658   40 367,954 2022 1 086,292 57,919 525,400   40 638,189 2023 1 277,253 55,858 507,322   40 692,211   Article 103(1), point (a), and Article 103(2) of Regulation (EU) 2021/2115 Article 17(5) of Regulation (EU) 2021/2115 Article 103(1), point (b), and Article 103(3) of Regulation (EU) 2021/2115     2024 1 632,136 5,000 590,214   40 602,078 2025 1 702,286 5,000 590,214 – 136,000 40 528,928 2026 1 807,987 5,000 590,214 – 149,000 40 541,227 2027 1 981,419 5,000 590,214 – 155,000 40 495,795 ’

Other acts of the same type
Commission Delegated Regulation (EU) 2023/1448 of 10 May 2023 amending Delegated Regulation (EU) 2022/127 as regards the payment of advances under the school scheme and correcting that RegulationCommission Implementing Regulation (EU) 2023/931 of 8 May 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the traditional food from a third country infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/932 of 8 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the approval period of the active substance pyridalyl (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/942 of 8 May 2023 amending Annex I to Implementing Regulation (EU) 2023/594 laying down special control measures for African swine fever (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/1120 of 7 May 2023 granting a Union authorisation for the single biocidal product “APESIN Handaktiv” in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Council Implementing Regulation (EU) 2023/913 of 4 May 2023 implementing Article 9 of Regulation (EC) No 1183/2005 concerning restrictive measures in view of the situation in the Democratic Republic of the CongoCommission Regulation (EU) 2023/917 of 4 May 2023 correcting the Polish language version of Regulation (EU) No 651/2014 declaring certain categories of aid compatible with the internal market in application of Articles 107 and 108 of the Treaty (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/907 of 3 May 2023 correcting the French language version of Implementing Regulation (EU) 2022/1412 concerning the authorisation of ylang ylang essential oil from Cananga odorata (Lam) Hook f. & Thomson as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/908 of 3 May 2023 amending for the 335th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCommission Regulation (EU) 2023/923 of 3 May 2023 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards lead and its compounds in PVC (Text with EEA relevance)Commission Delegated Regulation (EU) 2023/1615 of 3 May 2023 supplementing Regulation (EU) 2021/23 of the European Parliament and of the Council with regard to regulatory technical standards specifying the conditions under which compensation, cash equivalent of such compensation or any proceeds that are due pursuant to Article 63(1) of that Regulation are to be passed on to clients and indirect clients and the conditions under which passing on is to be considered proportionate (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next